Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
2.270
+0.060 (2.71%)
At close: Mar 17, 2026, 4:00 PM EDT
2.300
+0.030 (1.32%)
After-hours: Mar 17, 2026, 5:50 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $30.6 million as of March 17, 2026. Its market cap has decreased by -13.37% in one year.
Market Cap
30.60M
Enterprise Value
31.49M
1-Year Change
-13.37%
Ranking
Category
Stock Price
$2.27
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $30.60M, a decrease of -65.48%. That is a compound annual growth rate of -20.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 29.79M | 110.69% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 31.84M |
| BriaCell Therapeutics | 31.52M |
| Hyperion DeFi | 31.18M |
| PDS Biotechnology | 30.99M |
| Cue Biopharma | 30.42M |
| CEL-SCI | 29.86M |
| Dyadic International | 29.29M |
| Outlook Therapeutics | 29.23M |